Kimngan Hong Nguyen, MD
Family Practice · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office at (650) 903-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Medicaid work
$458 in 2024
Medicaid paid $458 for 15 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 15 | $458 |
| 2024 | 15 | 1 | 15 | $458 |
| 2023 | 16 | 1 | 15 | $215 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 16 | $215 |
Drugs they prescribed that Part D paid
$92,875
Pharmacies billed $92,875 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (45 of 1,989) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,830 generic and 139 brand-name prescriptions · $92,875 in drug cost · 92 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 24 | $17,775 | $741 |
| Jardiance | 17 | $8,773 | $516 |
| Levothyroxine | 115 | $2,104 | $18 |
| Atorvastatin | 146 | $1,828 | $13 |
| Wixela Inhub | 13 | $1,631 | $125 |
See all 49 drugs
| Ozempic | 24 | $17,775 | $741 |
| Jardiance | 17 | $8,773 | $516 |
| Levothyroxine | 115 | $2,104 | $18 |
| Atorvastatin | 146 | $1,828 | $13 |
| Wixela Inhub | 13 | $1,631 | $125 |
| Gabapentin | 51 | $1,457 | $29 |
| Losartan | 86 | $1,052 | $12 |
| Triamcinolone Acetonide | 32 | $978 | $31 |
| Amlodipine Besylate | 81 | $927 | $11 |
| Lisinopril | 64 | $783 | $12 |
| Fluticasone Propionate | 35 | $724 | $21 |
| Trospium Chloride | 15 | $526 | $35 |
| Famotidine | 41 | $505 | $12 |
| Pantoprazole | 33 | $499 | $15 |
| Simvastatin | 36 | $420 | $12 |
| Hydrochlorothiazide | 35 | $403 | $12 |
| Tamsulosin | 27 | $398 | $15 |
| Lisinopril-Hydrochlorothiazide | 28 | $387 | $14 |
| Metoprolol | 33 | $370 | $11 |
| Metoprolol | 32 | $364 | $11 |
| Metformin | 31 | $336 | $11 |
| Potassium Chloride | 13 | $326 | $25 |
| Clopidogrel | 16 | $305 | $19 |
| Alendronate | 31 | $305 | $10 |
| Atenolol | 27 | $298 | $11 |
| Ibuprofen | 25 | $283 | $11 |
| Albuterol Sulfate Hfa | 16 | $260 | $16 |
| Mirtazapine | 12 | $253 | $21 |
| Hydrocodone-Acetaminophen | 14 | $246 | $18 |
| Metformin Hcl Er | 29 | $241 | $8 |
| Furosemide | 22 | $239 | $11 |
| Carvedilol | 23 | $238 | $10 |
| Hydrocortisone | 20 | $237 | $12 |
| Omeprazole | 21 | $207 | $10 |
| Nortriptyline | 11 | $204 | $19 |
| Lovastatin | 17 | $198 | $12 |
| Ciclopirox | 11 | $190 | $17 |
| Nitrofurantoin Mono-Macro | 20 | $182 | $9 |
| Rosuvastatin | 16 | $181 | $11 |
| Spironolactone | 17 | $170 | $10 |
| Glipizide | 14 | $153 | $11 |
| Pravastatin | 11 | $138 | $13 |
| Meloxicam | 20 | $129 | $6 |
| Allopurinol | 12 | $127 | $11 |
| Trazodone | 13 | $124 | $10 |
| Tramadol | 18 | $114 | $6 |
| Sulfamethoxazole-Trimethoprim | 12 | $83 | $7 |
| Prednisone | 11 | $72 | $7 |
| Azithromycin | 11 | $70 | $6 |
Year by year
| 2024 | 1,989 | 339 | 2% (45) | 7% | $92,875 |
| 2023 | 1,450 | 341 | 3% (36) | 8% | $72,063 |
| 2022 | 241 | 111 | None | None | $10,121 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Pradaxa | 13 | $2,644 | $203 |
| Atorvastatin | 91 | $1,464 | $16 |
| Losartan | 82 | $999 | $12 |
| Levothyroxine | 41 | $863 | $21 |
| Potassium Chloride | 21 | $723 | $34 |
| Amlodipine Besylate | 56 | $675 | $12 |
| Lisinopril | 46 | $550 | $12 |
| Gabapentin | 20 | $536 | $27 |
| Hydrochlorothiazide | 51 | $533 | $10 |
| Tamsulosin | 26 | $408 | $16 |
| Fenofibrate | 14 | $395 | $28 |
| Metformin Hcl Er | 36 | $346 | $10 |
| Hydrocodone-Acetaminophen | 20 | $334 | $17 |
| Bisoprolol | 11 | $326 | $30 |
| Metoprolol | 32 | $305 | $10 |
| Metformin | 30 | $297 | $10 |
| Rosuvastatin | 23 | $277 | $12 |
| Trazodone | 19 | $272 | $14 |
| Lisinopril-Hydrochlorothiazide | 19 | $259 | $14 |
| Spironolactone | 21 | $258 | $12 |
| Clopidogrel | 13 | $247 | $19 |
| Naproxen | 16 | $233 | $15 |
| Atenolol | 19 | $219 | $12 |
| Glipizide | 19 | $219 | $12 |
| Famotidine | 15 | $216 | $14 |
| Simvastatin | 18 | $209 | $12 |
| Triamcinolone Acetonide | 18 | $202 | $11 |
| Nano 2nd Gen Pen Needle | 11 | $200 | $18 |
| Omeprazole | 20 | $188 | $9 |
| Pantoprazole | 14 | $178 | $13 |
| Alendronate | 17 | $175 | $10 |
| Cephalexin | 18 | $165 | $9 |
| Nitrofurantoin Mono-Macro | 13 | $156 | $12 |
| Furosemide | 13 | $154 | $12 |
| Meloxicam | 17 | $117 | $7 |
| Allopurinol | 12 | $91 | $8 |
2022: 2 drugs
| Albuterol Sulfate Hfa | 14 | $222 | $16 |
| Atorvastatin | 16 | $189 | $12 |
Professional record
- NPI
- 1457918823
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 336 Checkers Dr Apt 104, San Jose, CA, 95133
- NPI first listed
- 2019-05-21
- NPI last updated
- 2022-11-21
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.